Top insulin maker Novo caught up in China’s widening drug probes

By Mette Fraende and Ben Hirschler COPENHAGEN/LONDON (Reuters) – Chinese authorities have visited a site operated by Danish drugmaker Novo Nordisk A/S , the world’s biggest maker of insulin, in the latest sign of a widening investigation into Western drugmakers. H. Lundbeck A/S , a smaller Danish drugs firm, also said its unit in Beijing had been visited by the authorities, while a Chinese newspaper reported an allegation from an unnamed person that French firm Sanofi SA had paid around 1.7 million yuan ($276,200) in bribes to hundreds of doctors in China in 2007. …